KingaI don't know when the company will acquire a new project, but in my opinion, patience will be rewarded here.The company is currently priced at well below asset backing as it is.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025